From DCAT Value Chain Insights (VCI)
Bristol-Myers Squibb has appointed Murdo Gordon executive vice president and chief commercial officer, a newly created position, effective June 21, 2016. Gordon will be responsible for leading the execution of commercial strategy across geographies. In this role, he will lead the company's worldwide markets in addition to a new worldwide commercialization team. Gordon will continue to report to Giovanni Caforio, chief executive officer, and remain a member of his leadership team. Gordon most recently co-led the commercial organization as head of worldwide markets.
Gordon joined Bristol-Myers Squibb in 1989 and spent the first 14 years at the company in Canada, where he held positions of increasing responsibility in sales and marketing. Gordon moved into the company’s US operations in 2003, where he held senior commercial leadership positions in cardiovascular, neuroscience and market access. He led strategy and commercial operations as senior vice president for US oncology and immunoscience from 2011 to 2013, and served as president, US. from 2013 to 2015.
Source: Bristol-Myers Squibb
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription